{"id":"NCT00103506","sponsor":"Janssen Research & Development, LLC","briefTitle":"Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma","officialTitle":"A Randomized Controlled Study of DOXIL/CAELYX (Doxorubicin HCL Liposome Injection) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-12","primaryCompletion":"2014-05","completion":"2014-06","firstPosted":"2005-02-10","resultsPosted":"2015-05-25","lastUpdate":"2015-10-19"},"enrollment":646,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Bortezomib (VELCADE)","otherNames":[]},{"type":"DRUG","name":"Bortezomib (VELCADE)","otherNames":[]},{"type":"DRUG","name":"Doxorubicin hydrochloride (DOXIL/CAELYX)","otherNames":[]}],"arms":[{"label":"VELCADE (bortezomib) monotherapy","type":"ACTIVE_COMPARATOR"},{"label":"DOXIL/CAELYX in combination with VELCADE (bortezomib)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate time to progression, overall survival, response rate and safety for the two open-label treatment groups; DOXIL/CAELYX in combination with VELCADE vs. VELCADE monotherapy.","primaryOutcome":{"measure":"Time to Progression (TTP)","timeFrame":"Up to 1 year and 4 months (From date of first participant randomization [20 December 2004] up to interim analysis cut-off date [28 April 2006])","effectByArm":[{"arm":"Velcade (Bortezomib) Monotherapy","deltaMin":6.5,"sd":null},{"arm":"Doxil/Caelyx Plus Velcade (Bortezomib)","deltaMin":9.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":108,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","Czechia","France","Israel","Netherlands","Poland","Portugal","Russia","Singapore","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["25261096","18300257","17679727"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":105,"n":318},"commonTop":["Nausea","Diarrhoea","Fatigue","Constipation","Thrombocytopenia"]}}